Microcarriers are small bead like materials that support the matrix which facilitate the growth of adherent cells. Cell culture techniques are now used extensively to study animal cell function, structure, and differentiation and to manufacture several significant biological materials, such as vaccines, hormones, enzymes, antibodies, interferons, and nucleic acids. For the survival and replication majority of cells in cell culture require attachment to a surface and are anchorage-dependent. Thus, these microcarriers support the growth of anchorage-dependent cells. Microcarriers are widely used in the large-scale commercial production of cell-based vaccines and biologics (proteins). Thus, rise in demand for biologics and cell-based vaccines drives the microcarriers market. Increase in cell-based research, rise in public and private funding, and technological advancement propel the global market. However, high cost of cell-based research is likely to hinder the global microcarriers market during forecast period.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52350
The global microcarriers market can be segmented based on product, application, end-user, and region. In terms of product, the global market can be bifurcated into equipment and consumables. The equipment segment can be divided into culture vessels, bioreactors, filtration devices, cell counters, and accessories. The consumables segment can be sub-segmented into microcarrier beads, media, and reagents. The consumables segment is anticipated to expand at considerable CAGR during forecast period owing to continuous use of various reagents and media for various cell culture processes and applications. Based on application, the market can be segregated into vaccine manufacturing, cell therapy, and other applications. Vaccine manufacturing is expected to hold a significant share of the market due to the surge in demand for cell-based vaccines. In terms of end-user, the microcarriers market can be categorized into pharmaceutical & biotechnology companies, contract research & manufacturing organizations, and research & development institutes. The pharmaceutical & biotechnology segment is expected to hold a dominant share of the market due to the surge in demand for cell-based vaccines, increase in pharmaceutical research & development expenditure, and expansion in application areas of microcarriers.
Request COVID Analysis on Microcarriers Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=52350
Based on region, the global microcarriers market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America and Europe constituted for a large share of the global microcarriers market due to the rise in demand for cell-based vaccines and biologics, developed health care infrastructure, presence of key players, and increase in research & development activities. Technological advancement in cell-based research and rise in the number of venture capital investments further drive the global microcarriers market in North America and Europe. The market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period. Rise in investments by various key players in the region, increase in awareness, developments in health care infrastructure, and favorable regulatory reforms propel the microcarriers market in Asia Pacific. The market in Latin America and Middle East & Africa is projected to expand at considerable pace during the forecast period owing to the increase in investments from market players in these regions.
Pre Book Microcarriers Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=52350<ype=S
Key players operating in the global microcarriers market include Thermo Fisher Scientific, GE Healthcare, Merck KGaA, Danaher Corporation, Lonza, Eppendorf AG, Becton, Dickinson and Company, HiMedia Laboratories, Corning Incorporated, and Sartorius AG.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
Overview:The global Microcarriers Market Size is showing positive signs of surpassing a valuation of USD 1.18 Billion with a moderately strong CAGR of 5.9% that can be taken into consideration for a forecast period defining the market from 2018 to 2023.
It can benefit from a number of factors like large culture surface area, better cell yields, and reduced risk of contamination can provide advantage to the global market for microcarriers.
Other factors like the manufacturing of biologics and cell therapies, can make adverse impact on the market growth due to its high cost.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6911Segmentation:The global microcarriers market can be assessed on the findings of segments like product type, application, and end-user.
MRFR’s report provides a detailed glimpse into the market that can be shared to make a better assessment of the market.
Regional Analysis:The Americas is topping the chart as the research scope is better than other regions due to its superior infrastructure and favorable reimbursement scenarios.
Competitive Landscape:Companies that have been included in the global market for microcarriers are GENERAL ELECTRIC COMPANY, Thermo Fisher Scientific Inc., Sartorius AG, Corning Incorporated, Becton, Dickinson and Company, Danaher, Merck KGaA, HiMedia Laboratories, Eppendorf AG, Lonza, and others.
Microcarriers Market ScopeMicrocarriers are a support matrix which allows the growth of adherent cells in a cell culture.
The global microcarriers market report by Market Research Future (MRFR) contains trends, insights, factors, and challenges facing the industry for the period of 2018 to 2023 (forecast period).
The impact of the COVID-19 pandemic and its indelible impact on the industry are explored and discussed in the report.The global microcarriers market held a market value of approximate USD 1.18 billion in 2017.
It is estimated to register a CAGR of 5.9% during the forecast period of 2018–2023.
Benefits of microcarriers such as low contamination risk, large culture surface area, and high dividends on cells are likely to drive its demand among research institutes and laboratories.
Collaborations and partnerships for the launch of new mediums for cultivating microcarriers can drive its growth significantly.Investments in research and development coupled with focus of manufacturers on improving stem cell techniques can drive the global microcarriers market growth.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
